Guardant Health, Inc. (GH)

Guardant Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-416.28	-436.37	-479.45	-654.59	-405.67
Depreciation & Amortization	39.74	42.39	42.88	35.96	22.27
Other Amortization	-	-	-	2.57	2.56
Loss (Gain) From Sale of Investments	12.71	37.63	-64.21	17.65	12.85
Stock-Based Compensation	166.22	140.41	90.76	94.69	151.45
Other Operating Activities	27.29	36.95	31.2	132.7	47.99
Change in Accounts Receivable	-28.18	-21.39	8.38	0.38	-44.35
Change in Inventory	-14.79	-9.14	-10.35	-20.93	-7.96
Change in Accounts Payable	52.75	-2.82	5.19	60.33	34.8
Change in Unearned Revenue	19.46	18.66	1.73	9.87	2.78
Change in Other Net Operating Assets	-43.67	-46.18	48.89	11.91	-25.73
Operating Cash Flow	-184.76	-239.86	-324.98	-309.46	-209.02
Capital Expenditures	-48.31	-35.09	-20.49	-77.46	-75.04
Cash Acquisitions	-58.99	-	-	-	-
Investment in Securities	-519.91	-226.22	860.74	227.28	11.88
Investing Cash Flow	-627.2	-261.31	840.25	149.82	-63.16
Long-Term Debt Issued	402.5	-	-	-	-
Net Debt Issued (Repaid)	402.5	-	-	-	-
Issuance of Common Stock	377.81	14.84	503.68	11.94	17.87
Repurchase of Common Stock	-75.55	-15.68	-11.2	-7.88	-83.76
Other Financing Activities	-33.63	-0.15	-15.1	-193.16	-0.93
Financing Cash Flow	671.13	-1	477.38	-189.09	-66.82
Foreign Exchange Rate Adjustments	0.49	-1.77	-0.91	-1.6	-1.69
Net Cash Flow	-140.34	-503.93	991.74	-350.34	-340.69
Free Cash Flow	-233.07	-274.94	-345.46	-386.92	-284.05
Free Cash Flow Margin	-23.73%	-37.20%	-61.26%	-86.07%	-76.02%
Free Cash Flow Per Share	-1.86	-2.24	-3.08	-3.79	-2.80
Cash Interest Paid	3.77	-	-	-	-
Cash Income Tax Paid	0.87	1.01	1.97	1.33	0.39
Levered Free Cash Flow	-88.11	-148.78	-180.7	-295.57	-123.48
Unlevered Free Cash Flow	-85.67	-147.16	-179.09	-296.52	-124.43
Change in Working Capital	-14.43	-60.86	53.84	61.56	-40.47

Updated Feb 19, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q